4//SEC Filing
KYTHERA BIOPHARMACEUTICALS INC 4
Accession 0001104659-15-068854
CIK 0001436304operating
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 2:14 PM ET
Size
13.5 KB
Accession
0001104659-15-068854
Insider Transaction Report
Form 4
Samuels Camille D
Director10% Owner
Transactions
- Disposition to Issuer
Common Stock
2015-10-01−13,685→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−8,400→ 0 totalExercise: $33.26Exp: 2024-06-05→ Common Stock (8,400 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−11,591→ 0 totalExercise: $53.26Exp: 2025-06-02→ Common Stock (11,591 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−5,672→ 0 totalExercise: $16.00Exp: 2022-10-10→ Common Stock (5,672 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−6,618→ 0 totalExercise: $21.65Exp: 2023-06-04→ Common Stock (6,618 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger dated as of August 4, 2015 (the "Merger Agreement"), by and among Allergan plc (formerly known as Actavis plc) ("Allergan"), Keto Merger Sub, Inc. (a wholly owned subsidiary of Allergan) and Issuer, whereby each share of Issuer common stock was canceled in exchange for $75.00 in cash, without interest.
- [F2]Pursuant to the Merger Agreement, each option to purchase common stock was canceled and paid in cash assuming a stock price of $75.00.
Documents
Issuer
KYTHERA BIOPHARMACEUTICALS INC
CIK 0001436304
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001436304
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 2:14 PM ET
- Size
- 13.5 KB